Stay updated on rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.
Latest updates to the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check15 days agoChange DetectedThe page has removed extensive details about a Phase III clinical trial for idiopathic pulmonary fibrosis, including the study's objectives, inclusion and exclusion criteria, and specific treatment protocols. It has added a new revision number and a reference to an EudraCT number.SummaryDifference13%
- Check121 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check143 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check150 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with the study's location.SummaryDifference1%
- Check164 days agoChange DetectedThe website has been updated from version 2.12.1 to 2.12.2.SummaryDifference0.0%
- Check186 days agoChange DetectedThe website has been updated from version v2.11.2 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.